David J. Villeneuve

Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance

Stacey L. Hembruff, Monique L. Laberge, David J. Villeneuve et al. · BMC Cancer · 2008 · 83 citations · Full text

Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure

Baoqing Guo, David J. Villeneuve, Stacey L. Hembruff et al. · Breast Cancer Research and Treatment · 2004 · 70 citations

Breast Oncology, Oncology, Health Sciences +10

cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance

David J. Villeneuve, Stacey L. Hembruff, Zachary Veitch et al. · Breast Cancer Research and Treatment · 2005 · 54 citations

Cdna Microarray Analysis, Drug Resistance Analysis, Breast Oncology +11

Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells

Kerry Reed, Stacey L. Hembruff, Monique L. Laberge et al. · Epigenetics · 2008 · 53 citations · Full text

Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells

Antony Chadderton, David J. Villeneuve, Stefan Glück et al. · Breast Cancer Research and Treatment · 2000 · 41 citations

Breast Oncology, Paclitaxel-induced Apoptosis, Medicine +9